Email Print Friendly Share –Data strongly support expanding development into mast cell driven diseases––Data presented in a late-breaking session at EAACI Annual Congress 2020– HAMPTON,... Read More →

Email Print Friendly Share CALGARY, Alberta, June 05, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) is pleased to announce the Company... Read More →

Email Print Friendly Share $60 million funding for manufacturing of NVX-CoV2373 10 million doses to be delivered to DoD in 2020 GAITHERSBURG, Md., June 04,... Read More →

Email Print Friendly Share GENEVA, Switzerland and BOSTON, MA (June 4, 2020) – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing... Read More →

Email Print Friendly Share ITRI’s positive pressure testing booth With ITRI’s positive pressure testing booth, medical staff can just wear masks and normal lab gowns... Read More →

Email Print Friendly Share New York, June 01, 2020 (GLOBE NEWSWIRE) — The global pharmacovigilance market is expected to reach USD 12.98 Billion by 2027, according to... Read More →

Email Print Friendly Share First-in-class TIM-based non-gene edited allogeneic CAR-T candidate, CYAD-101, shows encouraging clinical activity with no evidence of graft-versus-host disease in relapsed/refractory metastatic... Read More →

Email Print Friendly Share SANTA ANA, Calif., May 29, 2020 (GLOBE NEWSWIRE) — NKMax America, a biotechnology company harnessing the power of the body’s immune... Read More →

Email Print Friendly Share HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers,... Read More →

Email Print Friendly Share Geneva, Switzerland and Boston, MA – May 29, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing... Read More →